Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Bioanalytical Systems (BASI) Competitors

Bioanalytical Systems logo

BASI vs. LUNA, AIKI, DKDCA, HYPR, GUTS, SRTS, ADAG, ACHV, QNCX, and IVVD

Should you be buying Bioanalytical Systems stock or one of its competitors? The main competitors of Bioanalytical Systems include Luna Innovations (LUNA), AIkido Pharma (AIKI), Data Knights Acquisition (DKDCA), Hyperfine (HYPR), Fractyl Health (GUTS), Sensus Healthcare (SRTS), Adagene (ADAG), Achieve Life Sciences (ACHV), Quince Therapeutics (QNCX), and Invivyd (IVVD).

Bioanalytical Systems vs. Its Competitors

Bioanalytical Systems (NASDAQ:BASI) and Luna Innovations (NASDAQ:LUNA) are both small-cap commercial physical research industry companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, media sentiment, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

In the previous week, Bioanalytical Systems' average media sentiment score of 0.00 equaled Luna Innovations'average media sentiment score.

Company Overall Sentiment
Bioanalytical Systems Neutral
Luna Innovations Neutral

Luna Innovations has higher revenue and earnings than Bioanalytical Systems.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bioanalytical Systems$60.47M0.34-$4.68M-$0.35-5.23
Luna Innovations$116.61M0.26$9.28MN/AN/A

10.6% of Bioanalytical Systems shares are held by institutional investors. Comparatively, 87.5% of Luna Innovations shares are held by institutional investors. 11.5% of Bioanalytical Systems shares are held by insiders. Comparatively, 7.6% of Luna Innovations shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Luna Innovations has a net margin of 0.00% compared to Bioanalytical Systems' net margin of -7.75%. Luna Innovations' return on equity of 0.00% beat Bioanalytical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Bioanalytical Systems-7.75% -42.74% -6.38%
Luna Innovations N/A N/A N/A

Bioanalytical Systems has a beta of 1.92, suggesting that its stock price is 92% more volatile than the S&P 500. Comparatively, Luna Innovations has a beta of 2.01, suggesting that its stock price is 101% more volatile than the S&P 500.

Summary

Luna Innovations beats Bioanalytical Systems on 7 of the 9 factors compared between the two stocks.

Get Bioanalytical Systems News Delivered to You Automatically

Sign up to receive the latest news and ratings for BASI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BASI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BASI vs. The Competition

MetricBioanalytical SystemsCommercial Physical Research IndustryMedical SectorNASDAQ Exchange
Market Cap$20.37M$19.90M$5.45B$9.62B
Dividend YieldN/AN/A4.61%4.14%
P/E Ratio-4.36N/A29.8724.86
Price / Sales0.340.26449.7898.78
Price / Cash558.4057.2336.4258.36
Price / Book2.650.308.185.65
Net Income-$4.68M-$525K$3.26B$265.99M

Bioanalytical Systems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BASI
Bioanalytical Systems
N/A$1.83
-6.6%
N/A+16.7%$20.37M$60.47M-4.36397High Trading Volume
LUNA
Luna Innovations
0.272 of 5 stars
$0.95
+35.7%
N/A-65.9%$32.26M$116.61M0.00390Gap Up
AIKI
AIkido Pharma
N/A$4.50
-1.1%
N/A+263.6%$24.68MN/A-1.164High Trading Volume
DKDCA
Data Knights Acquisition
N/A$0.48
+0.7%
N/A-49.5%$2.49MN/A-2.542High Trading Volume
HYPR
Hyperfine
0.7945 of 5 stars
$1.20
+1.7%
$1.06
-11.7%
+5.5%$91.84M$12.89M-2.22190Upcoming Earnings
Gap Up
GUTS
Fractyl Health
2.5677 of 5 stars
$1.87
+0.5%
$11.00
+488.2%
-47.2%$91.10M$90K-1.01102News Coverage
Upcoming Earnings
High Trading Volume
SRTS
Sensus Healthcare
1.4365 of 5 stars
$5.25
-4.5%
$11.67
+122.2%
-45.1%$90.45M$41.81M52.5040News Coverage
Earnings Report
Analyst Forecast
Analyst Revision
Gap Down
ADAG
Adagene
2.9457 of 5 stars
$1.90
-0.6%
$8.00
+320.2%
-11.4%$90.20M$100K0.00260News Coverage
Analyst Forecast
Analyst Revision
Gap Up
ACHV
Achieve Life Sciences
1.904 of 5 stars
$2.62
+1.6%
$14.33
+447.1%
-44.6%$89.49MN/A-1.9620News Coverage
Earnings Report
QNCX
Quince Therapeutics
3.0075 of 5 stars
$1.69
+3.7%
$8.29
+390.3%
+139.1%$87.41MN/A-1.2260Upcoming Earnings
Analyst Forecast
Short Interest ↑
High Trading Volume
IVVD
Invivyd
3.017 of 5 stars
$0.72
-0.5%
$5.85
+707.9%
-24.0%$87.33M$25.38M-0.60100News Coverage
Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:BASI) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners